InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
5.17
+0.14 (2.78%)
At close: Oct 9, 2026, 4:00 PM EDT
5.05
-0.12 (-2.32%)
After-hours: Oct 9, 2026, 7:30 PM EDT
InterCure Market Cap
InterCure has a market cap or net worth of $64.47 million as of October 9, 2026. Its market cap has decreased by 28.86% in one year.
Market Cap
64.47M
Enterprise Value
108.92M
1-Year Change
-28.86%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since December 16, 2010, InterCure's market cap has increased from $1.77M to $64.47M, an increase of 3,545.77%. That is a compound annual growth rate of 25.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 62.72M | 13.00% |
| Dec 31, 2025 | 55.50M | -25.61% |
| Dec 31, 2024 | 74.61M | 27.32% |
| Dec 31, 2023 | 58.60M | -62.52% |
| Dec 29, 2022 | 156.35M | -47.90% |
| Dec 30, 2021 | 300.11M | 119.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cardiol Therapeutics | 147.10M |
| BGM Group | 138.48M |
| Organigram Global | 134.47M |
| Zhengye Biotechnology Holding | 114.21M |
| Cumberland Pharmaceuticals | 105.93M |
| Citius Oncology | 88.83M |
| Talphera | 56.06M |
| SCYNEXIS | 40.49M |